159 related articles for article (PubMed ID: 29180878)
1. Nimotuzumab combined with concurrent chemoradiotherapy benefits patients with advanced nasopharyngeal carcinoma.
Li Z; Li Y; Yan S; Fu J; Zhou Q; Huang X; Shen L
Onco Targets Ther; 2017; 10():5445-5458. PubMed ID: 29180878
[TBL] [Abstract][Full Text] [Related]
2. Nimotuzumab combined with chemoradiotherapy for the treatment of cervical cancer: A meta-analysis of randomized controlled trials.
Yuan Y; Chen J; Fang M; Guo Y; Sun X; Yu D; Guo Y; Xin Y
Front Oncol; 2022; 12():994726. PubMed ID: 36263226
[TBL] [Abstract][Full Text] [Related]
3. Cetuximab or Nimotuzumab Versus Cisplatin Concurrent with Radiotherapy for Local-Regionally Advanced Nasopharyngeal Carcinoma: a Meta-analysis.
Liang ZG; Lin GX; Ye JX; Li Y; Li L; Qu S; Liang X; Zhu XD
Asian Pac J Cancer Prev; 2018 May; 19(5):1397-1404. PubMed ID: 29802706
[TBL] [Abstract][Full Text] [Related]
4. Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy with or without nimotuzumab in the treatment of locally advanced nasopharyngeal carcinoma: a retrospective study.
Yang Z; Zuo Q; Liu R; Wu H; Xiong L; Jia J; Xiang Z
BMC Cancer; 2023 Nov; 23(1):1140. PubMed ID: 37996813
[TBL] [Abstract][Full Text] [Related]
5. Administration of nimotuzumab combined with cisplatin plus 5-fluorouracil as induction therapy improves treatment response and tolerance in patients with locally advanced nasopharyngeal carcinoma receiving concurrent radiochemotherapy: a multicenter randomized controlled study.
Lu Y; Chen D; Liang J; Gao J; Luo Z; Wang R; Liu W; Huang C; Ning X; Liu M; Huang H
BMC Cancer; 2019 Dec; 19(1):1262. PubMed ID: 31888551
[TBL] [Abstract][Full Text] [Related]
6. A systematic analysis in efficacy and safety of nimotuzumab combined with chemoradiotherapy in treatment of advanced nasopharyngeal carcinoma.
Sun Y; Wang Y; Guan L
Eur Arch Otorhinolaryngol; 2023 Mar; 280(3):1183-1190. PubMed ID: 36053358
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of concurrent chemoradiotherapy combined with nimotuzumab in the treatment of nasopharyngeal carcinoma with cervical lymph node metastasis.
Lu J; Wei J; Xiao X; Wei Y; Li M; Huang Y; Deng W; Wang H; Gui Z; Liu F; Jiang H; Zhang J; Weng J; Qu S
Eur Arch Otorhinolaryngol; 2023 May; 280(5):2479-2488. PubMed ID: 36577788
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness and cost-effectiveness analysis of nimotuzumab for the radiotherapy of locoregionally advanced nasopharyngeal carcinoma.
Fei Z; Xu T; Li M; Chen T; Li L; Qiu X; Chen C
Radiat Oncol; 2020 Oct; 15(1):230. PubMed ID: 33008416
[TBL] [Abstract][Full Text] [Related]
9. Concurrent chemoradiotherapy was associated with a higher severe late toxicity rate in nasopharyngeal carcinoma patients compared with radiotherapy alone: a meta-analysis based on randomized controlled trials.
Du CR; Ying HM; Kong FF; Zhai RP; Hu CS
Radiat Oncol; 2015 Mar; 10():70. PubMed ID: 25889937
[TBL] [Abstract][Full Text] [Related]
10. Combination treatment with cetuximab in advanced nasopharyngeal carcinoma patients: a meta-analysis.
Shen J; Sun C; Zhou M; Zhang Z
Onco Targets Ther; 2019; 12():2477-2494. PubMed ID: 31040691
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of concurrent chemoradiotherapy combined with nimotuzumab for low-risk T4 stage nasopharyngeal carcinoma: A pilot study.
Zhang S; Huang X; Zhou L; Lin S
Medicine (Baltimore); 2018 Sep; 97(38):e12503. PubMed ID: 30235761
[TBL] [Abstract][Full Text] [Related]
12. Nimotuzumab combined with concurrent chemoradiotherapy in locally advanced nasopharyngeal carcinoma: a retrospective analysis.
Liu ZG; Zhao Y; Tang J; Zhou YJ; Yang WJ; Qiu YF; Wang H
Oncotarget; 2016 Apr; 7(17):24429-35. PubMed ID: 27016412
[TBL] [Abstract][Full Text] [Related]
13. An open-label, single-arm phase II clinical study of induction chemotherapy and sequential Nimotuzumab combined with concurrent chemoradiotherapy in N3M0 stage nasopharyngeal carcinoma.
Zhang S; Huang X; Zhou L; Wu G; Lin J; Yang S; Chen J; Lin S
J BUON; 2018; 23(6):1656-1661. PubMed ID: 30610791
[TBL] [Abstract][Full Text] [Related]
14. Effect of nimotuzumab and PF induction chemotherapy combined with concurrent chemoradiotherapy in treating locally advanced nasopharyngeal carcinoma.
Gao M; Yuan T; Zhang F
J BUON; 2021; 26(1):116-123. PubMed ID: 33721441
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and survival analysis of nimotuzumab combined with concurrent chemoradiotherapy in the treatment of locally advanced nasopharyngeal carcinoma.
Wang L; Zhuang H; Xu X; Zhou J; Jiao Y
Front Oncol; 2023; 13():1129649. PubMed ID: 36814816
[TBL] [Abstract][Full Text] [Related]
16. Combining Nimotuzumab With Chemotherapy for Patients With Locally Advanced and Intermediate-Stage Nasopharyngeal Cancer: A Retrospective Comparison Study Using Five-Year, Real-World Survival Data.
Rachman A; Sari SR; Munandar A; Adham M; Hutajulu SH
Cureus; 2023 Nov; 15(11):e48804. PubMed ID: 38098929
[TBL] [Abstract][Full Text] [Related]
17. Improvement and prognosis analysis of nimotuzumab combined with TP regimen induction chemotherapy and sequential concurrent chemoradiotherapy in patients with locally advanced nasopharyngeal carcinoma.
Luan W; Yuan H; Hou W; Li J; Liu L
Am J Transl Res; 2022; 14(8):5630-5640. PubMed ID: 36105032
[TBL] [Abstract][Full Text] [Related]
18. Nimotuzumab Combined with Induction Chemotherapy and Concurrent Chemoradiotherapy in Unresectable Locally Advanced Hypopharyngeal Carcinoma: A Single Institution Experience in China.
Tian X; Xuan Y; Wu R; Gao S
Cancer Manag Res; 2020; 12():3323-3329. PubMed ID: 32494195
[TBL] [Abstract][Full Text] [Related]
19. Intensity-modulated radiotherapy plus nimotuzumab with or without concurrent chemotherapy for patients with locally advanced nasopharyngeal carcinoma.
Huang J; Zou Q; Qian D; Zhou L; Yang B; Chu J; Pang Q; Wang K; Zhang F
Onco Targets Ther; 2017; 10():5835-5841. PubMed ID: 29263680
[TBL] [Abstract][Full Text] [Related]
20. The efficacy and safety of concurrent chemoradiotherapy with induction chemotherapy
Liu Y; Yang L; Zhang S; Lin B
Transl Cancer Res; 2022 May; 11(5):1207-1218. PubMed ID: 35706809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
